News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PhytoMedical Technologies, Inc. (PYTO.OB) Advances Research of Patented Anti-Cancer Compound with Important Toxicity Tests


3/17/2008 10:35:44 AM

PRINCETON, N.J.--(BUSINESS WIRE)--PhytoMedical Technologies, Inc. (OTCBB: PYTO) (FWB: ET6), today announced that the Company will initiate the third phase of its drug development program, with researchers undertaking important toxicity studies of several select, patented anti-cancer compounds shown to successfully kill cells associated with several difficult-to-treat human cancers.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES